| Website | sensigen.com |
| Category | BioTech |
| Phone | 734-213-7600 |
| info@sensigen.com | |
| Employees |
| TOTAL | $250k |
| FUNDING TOTAL | $250k |
| Venture Round, 5/07 Ann Arbor SPARK | $250k |
SensiGen is a biotechnology company focused on gene-based molecular diagnostics. Their mission is to develop and commercialize nucleic acid tests that detect serious diseases earlier, monitor diseases more effectively, and lower overall healthcare costs. The Company has a late stage pipeline of high value diagnostic tests for cervical cancer, head & neck cancer, chronic kidney disease and lupus, all of which address very large markets with significant unmet needs.
